Member Info for easyp

http://pumpedordumped.com/data/searchcompany.php?search=AMER

How do you see the re financing going if at all? I am concerned about share dilution, rights issue or do you think they will renegotiate loans from Banks and creditors?

Oh look the usual suspects have forced the sp to a point where it is flat lining. Give it a few weeks and wait for those bandits to take Plexus into private hands on the cheap.....

I share your concerns over the management. The fields Amerisur own and exploit where once in the hands of an oil major, I hope that may be the case again. In short someone like Exxon will buy us out to build up reserves close to home and no where near the Gulf!.

Healthcare: Cancer breakthrough leads China�s biotech boom - https://www.ft.com/content/30b5a944-3b57-11e8-b9f9-de94fa33a81e via @FT Interesting read on CarT biotech in China, mentions Novartis. Do I believe the claimed results? No, not yet but one day a company will get the product and results 100% right and their sp will rocket.

http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=27322788&ArticleHeadline=Solid_State_margins_dragged_down_by_communications_arm

http://www.hl.co.uk/news/2018/4/12/mothercare-online-sales-return-to-growth-as-it-seeks-refinancing-deal Personally, will not invest until refinancing is sorted but I like the brand and believe Mothercare has a future. Whether that future is in conventional retail another matter.

Opportunity knocks but Amerisur is not pumping oil to take advantage of this drop in output! Holding this share really frustrating! https://www.zerohedge.com/news/2018-04-12/opec-oil-production-slides-venezuela-output-tumbles

Re share price fall, one should bare in mind that small caps on AIM are often prey to ramping or shorting. Remain invested, averaged down recently and as of today slightly down -5% ish. Spread wide and often the dealers offer poor selling price to small investors. That said, this company has an interesting product and a large potential market so buy and hold for me.

http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=27320031&ArticleHeadline=Playtech_to_buy_Italys_Snaitech_for_846m_as_it_moves_to_regulated_markets Remain a 888 fan, dividend payer, no debt and exciting prospects imo.

On the basis of brief research on FT I purchased shares this morning after the drop. As always a punt rather than an investment because of the "unknowns".

https://markets.ft.com/data/equities/tearsheet/financials?s=SOLI:LSE

What are in your opinion the fundamentals like? Debt, income, profits etc?

Reassuring, agree with your analysis and willing to wait for better news. I did wonder if this director was averaging down? Many purchased shares at 5p level so most underwater.

Not sure the price rise is due to stake building re bid attempt but rather geo political events in the Gulf and ME. Might take profits if today sees another 5% rise and buy back in over the summer months.

http://www.amadeus.com/web/amadeus/en_1A-corporate/Amadeus-Home/About-us/Our-technology/1319586749494-Page-AMAD_WhyAmadeusPpal Amadeus technology has been around for 30 years and many airlines use it for a variety of purposes. Once in place it will enhance the Flybe product. Not convinced implimentation will long, expensive and disruptive otherwise why buy it?

"Swiss pharmaceuticals company Novartis plans to spend $8.7bn buying AveXis, a US specialist in spinal muscular atrophy, a childhood wasting disease, in the latest strategic move by its new chief executive. Vas Narasimhan, who took over as Novartis�s boss in February, said Nasdaq-listed AveXis, which has yet to report any revenues, would significantly increase Novartis�s strength in gene therapies, and offered �multibillion sales potential�. The new Novartis boss has embarked on an acquisition spree as part of his plans to boost Novartis�s core business areas of innovative prescription medicines, as well as oncology, generics and eyecare."

http://www.lse.co.uk/AllNews.asp?code=ynniwxp6&headline=Crude_Oil_Rallies_On_Easing_Trade_Concerns Broadly, the market sees 2018 as a good year for commodities and with the value of the $ sliding here and there we should see a better return on our investments than this from Amerisur.

I am concerned about Russians in general because they have a nasty habit of stealing businesses off their non Russian shareholders but the orders are helpful. Given the money due to arrive from the sale of the jack up business I feel the sp way under fair value and willing to hold on in the hope of better days.

I am a bit wary of the markets in general right now so sold my AZN shares after the dividend payment but would buy back in if the trials proved encouraging.